Financials
Financial year 2025
Apotheek Rondpunt Sleidinge from Evergem, company number BE0414712612, closed financial year 2025 with a result of € 38,653 after tax. For that financial year Apotheek Rondpunt Sleidinge recorded a gross margin of € 67,939 and equity of € 374,624. Compared with financial year 2024, the result moved from € 36,070 to € 38,653. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 3, 2026.
€ 374,624
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 38,653
▲ 7% vs 2024
Profit after tax over the fiscal year.
€ 272,944
▲ 36% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 37,000 paid out
96 % of the profit went to the shareholders, mostly to DE VRIENDT - CHALMET (100 % of the shares). That is where the money ends up.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 41,476
▲ 54% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 463
▼ 69% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 70,560 | € 54,548 | € 64,198 | € 67,939 | ▲ 6% |
| Profit after taxes | € 44,969 | € 18,687 | € 36,070 | € 38,653 | ▲ 7% |
| Equity | € 354,214 | € 372,900 | € 372,971 | € 374,624 | |
| Total debts | € 218,965 | € 255,109 | € 208,110 | € 263,741 | ▲ 27% |
| Cash | € 162,094 | € 232,934 | € 201,391 | € 272,944 | ▲ 36% |
| Land & buildings | € 231,783 | € 222,463 | € 206,023 | € 189,584 | ▼ 8% |
| Retained profit | € 292,214 | € 310,900 | € 310,971 | € 312,624 | ▲ 1% |
| Dividend | € 44,000 | € 0 | € 36,000 | € 37,000 | ▲ 3% |
| Balance sheet total | € 573,179 | € 628,010 | € 581,080 | € 638,365 | ▲ 10% |
Key figures of Apotheek Rondpunt Sleidinge, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Rondpunt Sleidinge?
What happened at Apotheek Rondpunt Sleidinge in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- DE VRIENDT - CHALMET BV stepped down as director. NBB
- Linda De Vriendt stepped down as director. NBB
- Isabel Chalmet stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 38,653 (▲ 7% vs 2024). Source: NBB ↗
- Isabel Chalmet became a director. NBB
- Linda De Vriendt became a director. NBB
- DE VRIENDT - CHALMET BV became a director. NBB
- New establishment in Evergem. KBO
In short
From € 44,969 profit in 2022 to € 38,653 profit in 2025.
Paid € 8,214 in corporate taxes since 2022.
Best year ever: 2022, with € 44,969 profit.
Paid out € 117,000 in dividends to the owners in total.
A new publication or filing at Apotheek Rondpunt Sleidinge? We notify you, reason included.
Follow Apotheek Rondpunt SleidingeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DE VRIENDT - CHALMET comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek Rondpunt SleidingeThe shares are held by DE VRIENDT - CHALMET (99.9%).
Directors
According to the 2025 annual accounts
Director · represented by Chalmet Eric
since 2001 · until 2028
Linda De Vriendt
Director
since 2002 · until 2028
Isabel Chalmet
Director
since 2022 · until 2028
Shareholders
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Sleidinge-Dorp 27
9940 Evergem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0414.712.612
- VAT number
- BE 0414.712.612
- Registered office
- Sleidinge-Dorp 27, 9940 Evergem
- Names & denominations
- Apotheek Rondpunt Sleidinge
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 21 December 1974
- Peppol
- Active · Active since 21 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers